Dr John Bernard Marshall, MD | |
1 Jarrett White Rd, Tamc, HI 96859-5001 | |
(808) 433-6641 | |
(808) 433-1555 |
Full Name | Dr John Bernard Marshall |
---|---|
Gender | Male |
Speciality | Hospitalist |
Location | 1 Jarrett White Rd, Tamc, Hawaii |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922050970 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 6331 (Hawaii) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John Bernard Marshall, MD 1 Jarrett White Rd, Tripler Army Medical Center, Tripler Amc, HI 96859-5000 Ph: (808) 433-2620 | Dr John Bernard Marshall, MD 1 Jarrett White Rd, Tamc, HI 96859-5001 Ph: (808) 433-6641 |
News Archive
More and more, physicians are using the left ventricular assist device, or LVAD, to sustain patients who are awaiting heart transplants. The surgically implanted mechanical device takes over for weak and diseased hearts, acting as a bridge to transplant surgery.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPETĀ® technology to boost the oral bioavailability of an undisclosed proprietary compound.
Ten-week-old babies can learn from practicing walking months before they begin walking themselves say researchers.
The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).
› Verified 1 days ago